Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

ER-alpha antagonists and SERDs patented by Sanofi

April 27, 2021

Bayer initiates first-in-human study of BAY-2666605 in metastatic melanoma and advanced solid tumors

April 26, 2021

New phase I/II trial evaluates OBI-3424 for relapsed or refractory T-ALL and T-LBL

April 26, 2021

Phase II trial evaluates ALX-148 with pembrolizumab for advanced HNSCC

April 26, 2021

PHI-101 studied in phase I trial for relapsed or refractory AML

April 26, 2021

Merck KGaA presents c-KIT inhibitors with strong antitumor activity in GIST

April 26, 2021

Shanghai De Novo Pharmatech discloses G12C mutant GTPase KRAS inhibitors

April 26, 2021

MAPK 8 inhibitors patented by Wuhan LL Science and Technology Development

April 26, 2021

Canopy Growth Corp. describes new cannabinoid CB1/CB2 receptor modulators

April 26, 2021

Zenith agrees with Astellas to study ZEN-3694 with enzalutamide in metastatic CRPC

April 23, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...